Hashimoto's thyroiditis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Meets western medical diagnostic criteria for Hashimoto's thyroiditis; (2)Meets the Chinese medicine diagnostic criteria of liver depression, spleen deficiency and blood stasis obstruction syndrome; (3Age18- 65 years old and gender is not limited; (4)Informed consent, voluntary testing, informed consent process in accordance with GCP.
Exclusion criteria
Exclusion criteria: (1)Western clinical diagnosis of hypothyroidism, or subclinical hypothyroidism with TSH >10IU/ml; (2)In the last 6 months ,who with severe bleeding disorders, peptic ulcer, grade 3 hypertension, unstable angina, severe arrhythmia, cardiopulmonary insufficiency, pacemaker or stent implantation, history of myocardial infarction , or hepatic or renal insufficiency, ALT, AST higher than 2 times the upper limit of normal, or Cr higher than the upper limit of normal (higher than 84 umol/L for females and higher than 104 umol/L for males) ; (3) Those who have combined other medications for Hashimoto's thyroiditis (selenium yeast tablets, levothyroxine sodium tablets, glucocorticoids, vitamin D preparations) within the last 3 months; (4)Patients with malignant tumours; (5)Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum TPOAb antibody titre level test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum TgAb antibody titre level test;TCM symptom score; | — |
Countries
China
Contacts
Dongfang Hospital Beijing University of Chinese medicine